Suchergebnisse - Portal für Medizinische Datenmodelle (MDM-Portal)

Follow-Up - Breast Cancer - Adjuvant Follow-Up Form - 2279997v3.0 - Breast Cancer - Adjuvant Follow-Up Form

- 09.01.15 - 1 Formular, 9 Itemgruppen, 35 Datenelemente, 1 Sprache

Itemgruppen: CRF Header, Breast: Form Administration, Breast: Vital Status, Breast: Disease Follow-Up Status, Breast: Notice of Progression - Adjuvant, Breast: Notice of New Primary, Breast: Long-Term Toxicity, Breast: Long-Term Therapy, Comments

Breast Cancer - Adjuvant Follow-Up Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA188C45-CBCA-04EA-E034-0003BA12F5E7

Follow-Up - Breast Cancer - Advanced Disease Follow-Up Form - 2280124v3.0 - Breast Cancer - Advanced Disease Follow-Up Form

- 09.01.15 - 1 Formular, 8 Itemgruppen, 29 Datenelemente, 1 Sprache

Itemgruppen: CRF Header, Breast: Form Administration, Breast: Vital Status, Breast: Disease Follow-Up Status, Breast: Notice of Progression - Advanced Disease, Breast: Non-Protocol Therapy, Breast: Notice of New Primary, Comments

Breast Cancer - Advanced Disease Follow-Up Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA18BF01-4294-073C-E034-0003BA12F5E7

Breast Cancer NCT01242800 Follow-Up - E2108 Step 2 Follow-up Form - 3130846v1.0 - E2108 Step 2 Follow-up Form

- 20.09.21 - 1 Formular, 12 Itemgruppen, 67 Datenelemente, 1 Sprache

Itemgruppen: Header Module, Header, Amended Data, Report Period, Section I - Vital Status, Section II - Reporting Period, Status of Local-Regional Disease, CHEST WALL, Breast Involvement, Section IV - Status of Distant Disease, Circulating Tumor Cell (CTC) Enumeration, Comments

E2108 Step 2 Follow-up Form Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8E30083E-7422-9EAD-E040-BB89AD430E1D

Breast Cancer NCT00513292 Follow-Up - Z1041: Extended Follow-up Form - 2533635v1.0 - Z1041: Extended Follow-up Form

- 09.01.15 - 1 Formular, 5 Itemgruppen, 22 Datenelemente, 1 Sprache

Itemgruppen: Header Module, Header, Notice of First Recurrence/Progression, Notice of New Primary, Footer Module

Z1041: Extended Follow-up Form Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=211CBE88-1531-5AB5-E044-0003BA3F9857

Breast Cancer NCT01272037 Follow-Up - S1007 Follow-Up Form (64587) - 3140709v1.0 - S1007 Follow-Up Form (64587)

- 09.01.15 - 1 Formular, 3 Itemgruppen, 25 Datenelemente, 1 Sprache

Itemgruppen: Header Module, VITAL STATUS, Comments

S1007 Follow-Up Form (64587) Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90DA0C1C-751C-2248-E040-BB89AD435ECD

Breast Cancer NCT00601900 Follow-Up - CALGB 40503 FOLLOW-UP FORM - 2551098v1.0 - CALGB 40503 FOLLOW-UP FORM

- 08.01.15 - 1 Formular, 7 Itemgruppen, 38 Datenelemente, 1 Sprache

Itemgruppen: Header Module, Header, VITAL STATUS, NON-PROTOCOL THERAPY, NOTICE OF PROGRESSION, SKELETAL RELATED EVENTS, Footer Module

CALGB 40503 FOLLOW-UP FORM Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=2403F6CA-49D5-5F41-E044-0003BA3F9857

Breast Cancer NCT01101438 Follow-Up - NCIC MA.32 Telephone Follow-Up Report - 3025096v1.0 - NCIC MA.32 Telephone Follow-Up Report

- 27.09.21 - 1 Formular, 5 Itemgruppen, 17 Datenelemente, 1 Sprache

Itemgruppen: TIMING OF REPORT - TELEPHONE FOLLOW-UP, METFORMIN/PLACEBO ADMINISTRATION, SERIOUS ADVERSE EVENT - QUESTION, ADVERSE EVENTS ON TREATMENT - QUESTION, ADVERSE EVENTS

NCIC MA.32 Telephone Follow-Up Report A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=81DC7457-3943-EA84-E040-BB89AD43055B

Breast Cancer NCT00070564 Follow-Up - SOUTHWEST ONCOLOGY GROUP S0221 SUPPLEMENTARY FOLLOW UP FORM - 2101304v3.0 - SOUTHWEST ONCOLOGY GROUP S0221 SUPPLEMENTARY FOLLOW UP FORM

- 20.09.21 - 1 Formular, 3 Itemgruppen, 20 Datenelemente, 1 Sprache

Itemgruppen: Header, NOTICE OF PROGRESSION - ADJUVANT, Comments

SOUTHWEST ONCOLOGY GROUP S0221 SUPPLEMENTARY FOLLOW UP FORM Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BACD42B3-A5E1-6833-E034-0003BA12F5E7

Breast Cancer NCT00090974 Follow-Up - FORM 5M - MINIMAL FOLLOW-UP REPORT - 2064122v3.0 - FORM 5M - MINIMAL FOLLOW-UP REPORT

- 09.01.15 - 1 Formular, 7 Itemgruppen, 29 Datenelemente, 1 Sprache

Itemgruppen: PATIENT INFORMATION, STATUS, OTHER MALIGNANCIES OR MYELODYSPLASTIC SYNDROME, Header, COMMENTS, INVESTIGATOR SIGNATURE, CCRR MODULE

FORM 5M - MINIMAL FOLLOW-UP REPORT Quality Of Life Companion Study For JMA27 (NCIC-MA.27): A Randomized Phase III Trial Of Exemestane Versus Anastrozole With Or Without Celecoxib In Postmenopausal Women With Receptor Positive Primary Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=ABF3BD71-F788-63E3-E034-0003BA12F5E7

Breast Cancer NCT00513292 Follow-Up - Z1041: Early Termination of Follow-up (ETFU) - 2533765v1.0 - Z1041: Early Termination of Follow-up (ETFU)

- 09.01.15 - 1 Formular, 3 Itemgruppen, 10 Datenelemente, 1 Sprache

Itemgruppen: Header Module, Header, Footer Module

Z1041: Early Termination of Follow-up (ETFU) Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=211E6516-FD7F-6E79-E044-0003BA3F9857

Breast Cancer NCT00382018 Follow-Up - SOUTHWEST ONCOLOGY GROUP FOLLOW UP FORM - 2436449v1.0 - SOUTHWEST ONCOLOGY GROUP FOLLOW UP FORM

- 09.01.15 - 1 Formular, 3 Itemgruppen, 25 Datenelemente, 1 Sprache

Itemgruppen: Header, VITAL STATUS, Comments

SOUTHWEST ONCOLOGY GROUP FOLLOW UP FORM Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=07BF1268-207C-02AD-E044-0003BA3F9857

Breast Cancer NCT01272037 Follow-Up - S1007 Supplementary Follow-Up Form (FUS1007) - 3139763v1.0 - S1007 Supplementary Follow-Up Form (FUS1007)

- 09.01.15 - 1 Formular, 4 Itemgruppen, 22 Datenelemente, 1 Sprache

Itemgruppen: Header Module, NOTICE OF RECURRENCE/PROGRESSION - ADJUVANT, NOTICE OF RECURRENCE/PROGRESSION - ADJUVANT1, Comments

S1007 Supplementary Follow-Up Form (FUS1007) Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90C9DFFB-2463-84DB-E040-BB89AD437DC2

Stichworte

Inhaltsverzeichnis

Ausgewählte Datenmodelle